These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3791253)

  • 1. Clinical pharmacology of homoharringtonine.
    Savaraj N; Lu K; Dimery I; Feun LG; Burgess M; Keating M; Loo TL
    Cancer Treat Rep; 1986 Dec; 70(12):1403-7. PubMed ID: 3791253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial.
    Longnecker SM; Donehower RC; Cates AE; Chen TL; Brundrett RB; Grochow LB; Ettinger DS; Colvin M
    Cancer Treat Rep; 1987 Jan; 71(1):53-9. PubMed ID: 2878719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system (CNS) penetration of homoharringtonine (HHT).
    Savaraj N; Feun LG; Lu K; Leavens M; Moser R; Fields WS; Loo TL
    J Neurooncol; 1987; 5(1):77-81. PubMed ID: 3598625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of mitoxantrone.
    Ehninger G; Proksch B; Heinzel G; Woodward DL
    Cancer Treat Rep; 1986 Dec; 70(12):1373-8. PubMed ID: 3791250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of homoharringtonine in dogs.
    Lu K; Savaraj N; Feun LG; Guo ZG; Umsawasdi T; Loo TL
    Cancer Chemother Pharmacol; 1988; 21(2):139-42. PubMed ID: 3349562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of homoharringtonine administered as a 5-day continuous infusion.
    Coonley CJ; Warrell RP; Young CW
    Cancer Treat Rep; 1983; 67(7-8):693-6. PubMed ID: 6871884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites.
    Cohen BE; Egorin MJ; Kohlhepp EA; Aisner J; Gutierrez PL
    Cancer Treat Rep; 1986 Jul; 70(7):859-64. PubMed ID: 2424593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the human pharmacokinetics of isophosphamide (NSC-109724).
    Allen LM; Creaven PJ; Nelson RL
    Cancer Treat Rep; 1976 Apr; 60(4):451-8. PubMed ID: 1277221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical pharmacokinetics of vinorelbine (Navelbine).
    Wargin WA; Lucas VS
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies.
    Pinguet F; Culine S; Bressolle F; Astre C; Serre MP; Chevillard C; Fabbro M
    Clin Cancer Res; 2000 Jan; 6(1):57-63. PubMed ID: 10656432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
    Mok TS; Kanekal S; Lin XR; Leung TW; Chan AT; Yeo W; Yu S; Chak K; Leavitt R; Johnson P
    Cancer; 2001 Jun; 91(12):2369-77. PubMed ID: 11413527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxol metabolism and disposition in cancer patients.
    Walle T; Walle UK; Kumar GN; Bhalla KN
    Drug Metab Dispos; 1995 Apr; 23(4):506-12. PubMed ID: 7600920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide.
    Stewart DJ; Nundy D; Maroun JA; Tetreault L; Prior J
    Cancer Treat Rep; 1985 Mar; 69(3):269-73. PubMed ID: 3884152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.
    Heggie GD; Sommadossi JP; Cross DS; Huster WJ; Diasio RB
    Cancer Res; 1987 Apr; 47(8):2203-6. PubMed ID: 3829006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
    Leyva A; van Groeningen CJ; Kraal I; Gall H; Peters GJ; Lankelma J; Pinedo HM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5928-33. PubMed ID: 6498850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of [3H]levamisole in pigs after oral and intramuscular administration.
    Galtier P; Escoula L; Alvinerie M
    Am J Vet Res; 1983 Apr; 44(4):583-7. PubMed ID: 6869955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients.
    Bedikian AY; Vardeleon A; Smith T; Campbell S; Namdari R
    J Clin Pharmacol; 2006 Jul; 46(7):727-37. PubMed ID: 16809798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of homoharringtonine, a cytotoxic component of the evergreen plant Cephalotaxus harringtonia.
    Ni D; Ho DH; Vijjeswarapu M; Felix E; Rhea PR; Newman RA
    J Exp Ther Oncol; 2003; 3(1):47-52. PubMed ID: 12724858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.